Pembrolizumab plus lenvatinib performs well in MPM Presented ByDr Li-Anne Douma, Netherlands Cancer Institute - Antoni van Leeuwenhoek, the Netherlands TrialPhase 2, PEMMELA ConferenceWCLC 2022 23 August, 2022 10:34